Jun Cui

15.7k citations

171 papers · 12.7k · 3 hit papers · h-index 58

Impact in

Immunology top 0.5%
- interferon and immune responses
- Immune Response and Inflammation
- Immune cells in cancer
Epidemiology top 1%
- Autophagy in Disease and Therapy

Papers in

Immunology 57
- interferon and immune responses 37
- Immune Response and Inflammation 10
- Immune cells in cancer 6
Molecular Biology 53
- Inflammasome and immune disorders 15
- Ubiquitin and proteasome pathways 12
- Cell death mechanisms and regulation 7

Co-authors: Rong‐Fu Wang (20 shared papers)Helen Y. Wang (12 shared papers)Yaoxing Wu (33 shared papers)Shouheng Jin (34 shared papers)Weihong Xie (22 shared papers)Yunfei Qin (13 shared papers)Pingping Shen (12 shared papers)Xiaojun Xia (8 shared papers)
Journals: Autophagy (13 papers)Nature Communications (8 papers)Molecular Cell (6 papers)Advanced Science (6 papers)The EMBO Journal (5 papers)
Partner nations: China United States Australia

In The Last Decade

Jun Cui

164 papers receiving 12.6k citations

Jun Cui's Hit Papers

align trajectories log scale

Palmitoylation of GPX4 via the targetable ZDHHC8 determines ferroptosis sensitivity and antitumor immunity 2025 · 73 citations

What are hit papers?

Paper score: A paper's citations measured against the top-1% bar of its own field and year: the square root of citations ÷ bar, so 1 means right at the bar and 2 means four times its citations. The bar blends the citation counts that enter the top 1% of the paper's subfields in its year (weighted 89.5%), of those subfields over all years (0.5%) and of its year across all fields (10%); a subfield and year with fewer than 400 papers takes its year's bar. Papers from 2026 are not scored yet: in an unfinished year, when a paper appeared matters more than how it is cited.

Hit paper: A paper cited at least 1.5× the top-1% bar of its field and year: a paper score of at least √1.5.

2025 Nature Cancer
2022 Molecular Cell
2021 Autophagy

Peers

Countries citing papers authored by Jun Cui

Since Specialization

Citations

This map shows the geographic impact of Jun Cui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jun Cui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jun Cui more than expected).

Fields of papers citing papers by Jun Cui

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jun Cui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jun Cui. The network helps show where Jun Cui may publish in the future.

Co-authors

The 25 scholars most cited alongside Jun Cui, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jun Cui Line = papers co-authored together Jun Cui links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 171 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 1 Autophagy ·Daniel J. Klionsky, Amal Kamal Abdel‐Aziz, Sara Abdelfatah, Mahmoud Abdellatif, Asghar Abdoli, Steffen Abel, Hagai Abeliovich, Marie H. Abildgaard Hit paper breakdown →	2021	2067
2	NLRC5 Negatively Regulates the NF-κB and Type I Interferon Signaling Pathways Cell ·Jun Cui, Liang Zhu, Xiaojun Xia, Helen Y. Wang, Xavier D. Legras, Jun Ki Hong, Jiabing Ji, Pingping Shen	2010	381
3	TRIM14 Inhibits cGAS Degradation Mediated by Selective Autophagy Receptor p62 to Promote Innate Immune Responses Molecular Cell ·Meixin Chen, Qingcai Meng, Yunfei Qin, Puping Liang, Lian He, Yubin Zhou, Yongjun Chen, Junjiu Huang	2016	326
4	CLICs-dependent chloride efflux is an essential and proximal upstream event for NLRP3 inflammasome activation Nature Communications ·Tiantian Tang, Xueting Lang, Cong‐Fei Xu, Xiaqiong Wang, Tao Gong, Jun Cui, Li Ping Bai, Jun Wang	2017	308
5	Tumor-derived exosomes promote tumor progression and T-cell dysfunction through the regulation of enriched exosomal microRNAs in human nasopharyngeal carcinoma Oncotarget ·Shubiao Ye, Ze-Lei Li, Dong–Hua Luo, Bi‐Jun Huang, Yu-Suan Chen, Xiaoshi Zhang, Jun Cui, Yi-Xin Zeng	2014	305
6	Mechanisms and pathways of innate immune activation and regulation in health and cancer Human Vaccines & Immunotherapeutics ·Jun Cui, Yongjun Chen, Helen Y. Wang, Rong‐Fu Wang	2014	256
7	NLRX1 Negatively Regulates TLR-Induced NF-κB Signaling by Targeting TRAF6 and IKK Immunity ·Xiaojun Xia, Jun Cui, Helen Y. Wang, Liang Zhu, Satoko Matsueda, Qinfu Wang, Xiaoang Yang, Jun Ki Hong	2011	250
8	NLRP4 negatively regulates type I interferon signaling by targeting the kinase TBK1 for degradation via the ubiquitin ligase DTX4 Nature Immunology ·Jun Cui, Liang Zhu, Dan Liu, Zhou Songyang, Helen Y. Wang, Rong‐Fu Wang +1 other	2012	249
9	CXCL2/MIF-CXCR2 signaling promotes the recruitment of myeloid-derived suppressor cells and is correlated with prognosis in bladder cancer Oncogene ·Huanling Zhang, Y.L. Ye, M-X Li, S-B Ye, W-R Huang, T-T Cai, Jia He, J-Y Peng	2016	235
10	Mucosal Profiling of Pediatric-Onset Colitis and IBD Reveals Common Pathogenics and Therapeutic Pathways Cell ·Bing Huang, Zhanghua Chen, Lanlan Geng, Jun Wang, Huiying Liang, Huan Chen, Wanming Huang, Meiling Su	2019	234
11	Potential therapeutic effects of dipyridamole in the severely ill patients with COVID-19 Acta Pharmaceutica Sinica B ·Xiaoyan Liu, Zhe Li, Shuai Liu, Jing Sun, Zhanghua Chen, Min Jiang, Yinghua Wei, Xin Wang	2020	230
12	Perfluoroalkyl substance pollutants activate the innate immune system through the AIM2 inflammasome Nature Communications ·Tao Liu, Shuai Yang, Lin Sun, Zhiyao Zhao, Li-Yue Li, Yuanchu She, Xiaoyan Ye, Qing Bao	2021	217
13	Identify potent SARS-CoV-2 main protease inhibitors via accelerated free energy perturbation-based virtual screening of existing drugs Proceedings of the National Academy of Sciences ·Zhe Li, Xin Li, Yi‐You Huang, Yaoxing Wu, Runduo Liu, Lingli Zhou, Yuxi Lin, Deyan Wu	2020	212
14	Zika virus evades interferon-mediated antiviral response through the co-operation of multiple nonstructural proteins in vitro Cell Discovery ·Yaoxing Wu, Qingxiang Liu, Jie Zhou, Weihong Xie, Cheng Chen, Zefang Wang, Haitao Yang, Jun Cui	2017	192
15	USP19 suppresses inflammation and promotes M2-like macrophage polarization by manipulating NLRP3 function via autophagy Cellular and Molecular Immunology ·Tao Liu, Puping Liang, Xiaojuan Wang, Yukun Liu, Yuanchu She, Dan Wang, Zhi Wang, Zhiyong Guo	2020	191
16	Palmitoylation prevents sustained inflammation by limiting NLRP3 inflammasome activation through chaperone-mediated autophagy Molecular Cell ·Liqiu Wang, Xin Zhao, Ling Ma, Ping Zeng, Lingli Zhou, Yukun Liu, Shuai Yang, Zhe Cai Hit paper breakdown →	2022	187
17	Zika virus elicits inflammation to evade antiviral response by cleaving cGAS via NS1‐caspase‐1 axis The EMBO Journal ·Qingxiang Liu, Yaoxing Wu, Ling Ma, Zhenzhen Zhang, Tao Liu, Shouheng Jin, Yuanchu She, Yi‐Ping Li	2018	183
18	Tetherin Suppresses Type I Interferon Signaling by Targeting MAVS for NDP52-Mediated Selective Autophagic Degradation in Human Cells Molecular Cell ·Shouheng Jin, Shuo Tian, Weihong Xie, Tao Liu, Tianhao Duan, Yaoxing Wu, Jun Cui +1 other	2017	182
19	Gut epithelial TSC1/mTOR controls RIPK3-dependent necroptosis in intestinal inflammation and cancer Journal of Clinical Investigation ·Yadong Xie, Yifan Zhao, Wei Li, Kun Chen, Min Li, Xia Chen, Haiwei Zhang, Tiantian Li	2020	170
20	Porphyromonas gingivalis Promotes Colorectal Carcinoma by Activating the Hematopoietic NLRP3 Inflammasome Cancer Research ·Xi Wang, Yiqun Jia, Wenxin Mu, Xianrui Wu, Tao Liu, Xiangqi Liu, Juan Fang, Yizhao Luan	2021	170

About Jun Cui

Jun Cui is a scholar working on Immunology, Molecular Biology, Cancer Research, Epidemiology and Oncology, having authored 171 papers that have together received 12.7k indexed citations. Recurring topics across this work include interferon and immune responses (37 papers), Autophagy in Disease and Therapy (19 papers), Inflammasome and immune disorders (15 papers), Ubiquitin and proteasome pathways (12 papers), NF-κB Signaling Pathways (12 papers), Immune Response and Inflammation (10 papers), Cell death mechanisms and regulation (7 papers) and Immune cells in cancer (6 papers). The work is most often cited by research in Immunology (3.2k citations), Epidemiology (2k citations), Molecular Biology (4k citations), Cancer Research (743 citations) and Oncology (804 citations). Jun Cui has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Rong‐Fu Wang, Helen Y. Wang, Yaoxing Wu, Shouheng Jin, Weihong Xie, Yunfei Qin, Pingping Shen, Xiaojun Xia, Qingxiang Liu and Shuo Tian. Their work appears in journals such as Autophagy, Nature Communications, Molecular Cell, Advanced Science and The EMBO Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Jun Cui

Impact in

Papers in i

In The Last Decade

Jun Cui

Jun Cui's Hit Papers

Peers

Countries citing papers authored by Jun Cui

Fields of papers citing papers by Jun Cui

All Works

About Jun Cui

Explore authors with similar magnitude of impact

Papers in